TRINITY BIOTECH PLC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $4.7M | $15.2M |
| FY2020 | — | $-2.2M | $27.3M |
| FY2021 | — | $-319.0K | $25.9M |
| FY2022 | — | $-2.2M | $6.6M |
| FY2023 | — | $-23.9M | $3.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | — | $4.7M | $15.2M |
| FY2020 | — | $-2.2M | $27.3M |
| FY2021 | — | $-319.0K | $25.9M |
| FY2022 | — | $-2.2M | $6.6M |
| FY2023 | — | $-23.9M | $3.7M |